The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Novartis; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Puma Biotechnology; TapImmune Inc.; TTC Oncology
Research Funding - Celgene; Genentech; Pfizer
Travel, Accommodations, Expenses - Celgene
Other Relationship - Celgene
 
Consulting or Advisory Role - Eisai; Genentech; Lilly; Merck; Merrimack; Nektar; Novartis; Puma Biotechnology; Seagen
Research Funding - G1 Therapeutics; Lilly; Merck; Merrimack; Nektar; Novartis; Puma Biotechnology; Seagen; Tesaro
Patents, Royalties, Other Intellectual Property - Jones and Bartlett

Pharmacokinetic (PK) characterization of irinotecan liposome injection in patients (pts) with metastatic breast cancer (mBC).
 
Carey K. Anders
No Relationships to Disclose
 
Jasgit C Sachdev
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Anna Pedret-Dunn
Employment - Ipsen
 
Fiona Maxwell
Employment - Ipsen
 
Donald W. Northfelt
No Relationships to Disclose
 
Hyo S. Han
Consulting or Advisory Role - Pfizer
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); TapImmune Inc. (Inst); Tesaro (Inst)
 
Cynthia X. Ma
Consulting or Advisory Role - AstraZeneca; Biovica; Lilly; Merck; Novartis; Pfizer; Pfizer; Puma Biotechnology; Syndax; Tempus
Research Funding - Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; pfizer; Syndax